Document Detail


Efficacy and safety of midazolam and oxazepam in insomniacs.
MedLine Citation:
PMID:  6138067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a multicentre, double-blind, parallel study performed in 78 hospitalized patients who complained of mild, moderate or severe insomnia, the efficacy and safety of 15 mg midazolam were compared with those of 15 mg oxazepam, both orally administered. The results showed statistically significant better results in the onset of sleep in the patients treated with midazolam. Other sleep parameters, such as quality and duration of sleep as well as the condition of the patients on morning awakenings, were also improved in more patients treated with midazolam. Safety (clinical and biological) was very good in both groups of patients.
Authors:
R Lupolover; U Ballmer; J Helcl; J Escher; B Pavletic
Related Documents :
14768917 - Eeg-based indices of anaesthesia: correlation between bispectral index and patient stat...
17602037 - Sitting position does not alter minimum alveolar concentration for desflurane.
11737177 - The midazolam-induced paradox phenomenon is reversible by flumazenil. epidemiology, pat...
15768547 - Is postanesthesia care unit length of stay increased in hypothermic patients?
23241607 - Moderate elevations of high-sensitivity cardiac troponin i and b-type natriuretic pepti...
25280817 - Factors associated with severity of leukoaraiosis in first-ever lacunar stroke and athe...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  16 Suppl 1     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1983  
Date Detail:
Created Date:  1983-12-17     Completed Date:  1983-12-17     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  139S-143S     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Anxiety Agents / adverse effects,  therapeutic use*
Benzodiazepines / adverse effects,  therapeutic use*
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Midazolam
Middle Aged
Oxazepam / adverse effects,  therapeutic use*
Sleep Initiation and Maintenance Disorders / drug therapy*
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 12794-10-4/Benzodiazepines; 59467-70-8/Midazolam; 604-75-1/Oxazepam
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Midazolam dosage studies in institutionalized geriatric patients.
Next Document:  Midazolam and oxazepam in the treatment of insomnia in hospitalized patients.